Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             28 results found
no title author magazine year volume issue page(s) type
1 Adjuvant metronomic chemotherapy for locoregionally advanced nasopharyngeal carcinoma Kerbel, Robert S

398 10297 p. 278-279
article
2 Antibody response after second BNT162b2 dose in allogeneic HSCT recipients Redjoul, Rabah

398 10297 p. 298-299
article
3 A strategy to reduce the carbon footprint of clinical trials Adshead, Fiona

398 10297 p. 281-282
article
4 A time of crisis for the opioid epidemic in the USA The Lancet,

398 10297 p. 277
article
5 Cheryl Moyer: egalitarian in global health research Clark, Jocalyn

398 10297 p. 291
article
6 Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study Berdeja, Jesus G

398 10297 p. 314-324
article
7 Contrast-associated acute kidney injury in a patient with lower respiratory tract infection Cichowitz, Cody

398 10297 p. 340
article
8 FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement? Jafar, Tazeen H

398 10297 p. 283-284
article
9 Five priorities for universal COVID-19 vaccination Abecassis, Adrien

398 10297 p. 285-286
article
10 Helen Mae Murray Free Watts, Geoff

398 10297 p. 296
article
11 Heterogeneity of treatment effects in malignant pleural mesothelioma Di Maio, Massimo

398 10297 p. 301-302
article
12 Heterogeneity of treatment effects in malignant pleural mesothelioma – Authors' reply Baas, Paul

398 10297 p. 302
article
13 Inquest begins over South African mental health failings Scher, Marion

398 10297 p. 288
article
14 Lack of medicines in Mexico Agren, David

398 10297 p. 289-290
article
15 Mass infection is not an option: we must do more to protect our young Gurdasani, Deepti

398 10297 p. 297-298
article
16 Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial Chen, Yu-Pei

398 10297 p. 303-313
article
17 Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study
398 10297 p. 325-339
article
18 Paediatric surgery for congenital anomalies: the next frontier for global health Stokes, Sarah C

398 10297 p. 280-281
article
19 Past and present women pioneers in biomedical science Marks, Lara

398 10297 p. 293-295
article
20 Physical punishment and child outcomes: a narrative review of prospective studies Heilmann, Anja

398 10297 p. 355-364
article
21 Portrait or snapshot? Kneebone, Roger

398 10297 p. 292
article
22 Pre-eclampsia Chappell, Lucy C

398 10297 p. 341-354
article
23 Social unrest disrupts South African health care Makoni, Munyaradzi

398 10297 p. 287
article
24 The nutrition agenda must include tobacco control Klein, Jonathan D

398 10297 p. 300-301
article
25 The nutrition agenda must include tobacco control – Authors' reply Victora, Cesar G

398 10297 p. 301
article
26 Tocilizumab in COVID-19 therapy: who benefits, and how? Yang, Chengliang

398 10297 p. 299
article
27 Tocilizumab in COVID-19 therapy: who benefits, and how? Neumann, Avidan U

398 10297 p. 299-300
article
28 Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply Horby, Peter

398 10297 p. 300
article
                             28 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands